Definium Therapeutics, Inc. · NASDAQ:DFTX

Barrow Robert received 375,000 Definium Therapeutics, Inc. shares as an award (Form 4)

Traded Aug 12, 2026 · Filed Aug 12, 2026

On Aug 12, 2026, Barrow Robert (Director, Chief Executive Officer) received 375,000 Definium Therapeutics, Inc. shares as an award, leaving 1,473,246 shares. Filed Aug 12, 2026 (Form 4).

Awarded
375,000 shares
Holding after
1,473,246 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 12, 2026Common SharesAward375,0001,473,246Direct

Source

View original at SEC

Related